Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency

Effects of glucocorticoid treatment and surgery

Carla Scaroni, G. Favia, F. Lumachi, G. Opocher, G. Bonanni, F. Mantero, D. Armanini

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHDS) the presence of adrenal and testicular tumors had been described; however little is known about the effect of the enzymatic defect on fertility in males. We studied a male adult patient affected by 21OHDS for infertility, after a long period of discontinuation of glucocorticoid therapy and then during resumption of treatment and 8 months after monoadrenalectomy. The initial spermatic count revealed azoospermia and testicular needle aspiration showed a cytological picture consistent with prepuberty. The morphofunctional study revealed a right adrenal mass with reduced uptake at radioscan. Treatment was resumed with onset of impotency, which improved after reduction of the dose of glucocorticoids. The patient was monoadrenalectomised and his spermatic count increased. The patient shows that corticosteroid therapy in 21OHDS should be continued lifelong to avoid adrenal hyperplasia with possible areas of autonomy and to allow regular fertility. Impotence during treatment is probably due to a decrease of excessive adrenal androgens while testicular androgen production is still suppressed.

Original languageEnglish
Pages (from-to)41-43
Number of pages3
JournalExperimental and Clinical Endocrinology and Diabetes
Volume111
Issue number1
DOIs
Publication statusPublished - Feb 2003

Fingerprint

Glandular and Epithelial Neoplasms
Erectile Dysfunction
Infertility
Glucocorticoids
Sperm Count
Androgens
Fertility
Therapeutics
Azoospermia
Testicular Neoplasms
Needles
Hyperplasia
Adrenal Cortex Hormones
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency

Keywords

  • 21-Hydroxylase deficiency syndrome
  • Adrenal mass
  • Impotence
  • Infertility

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency : Effects of glucocorticoid treatment and surgery. / Scaroni, Carla; Favia, G.; Lumachi, F.; Opocher, G.; Bonanni, G.; Mantero, F.; Armanini, D.

In: Experimental and Clinical Endocrinology and Diabetes, Vol. 111, No. 1, 02.2003, p. 41-43.

Research output: Contribution to journalArticle

@article{8e26851278734c97859950a0e9518820,
title = "Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency: Effects of glucocorticoid treatment and surgery",
abstract = "In untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHDS) the presence of adrenal and testicular tumors had been described; however little is known about the effect of the enzymatic defect on fertility in males. We studied a male adult patient affected by 21OHDS for infertility, after a long period of discontinuation of glucocorticoid therapy and then during resumption of treatment and 8 months after monoadrenalectomy. The initial spermatic count revealed azoospermia and testicular needle aspiration showed a cytological picture consistent with prepuberty. The morphofunctional study revealed a right adrenal mass with reduced uptake at radioscan. Treatment was resumed with onset of impotency, which improved after reduction of the dose of glucocorticoids. The patient was monoadrenalectomised and his spermatic count increased. The patient shows that corticosteroid therapy in 21OHDS should be continued lifelong to avoid adrenal hyperplasia with possible areas of autonomy and to allow regular fertility. Impotence during treatment is probably due to a decrease of excessive adrenal androgens while testicular androgen production is still suppressed.",
keywords = "21-Hydroxylase deficiency syndrome, Adrenal mass, Impotence, Infertility",
author = "Carla Scaroni and G. Favia and F. Lumachi and G. Opocher and G. Bonanni and F. Mantero and D. Armanini",
year = "2003",
month = "2",
doi = "10.1055/s-2003-37499",
language = "English",
volume = "111",
pages = "41--43",
journal = "Experimental and Clinical Endocrinology and Diabetes",
issn = "0947-7349",
publisher = "Thieme",
number = "1",

}

TY - JOUR

T1 - Unilateral adrenal tumor, erectile dysfunction and infertility in a patient with 21-hydroxylase deficiency

T2 - Effects of glucocorticoid treatment and surgery

AU - Scaroni, Carla

AU - Favia, G.

AU - Lumachi, F.

AU - Opocher, G.

AU - Bonanni, G.

AU - Mantero, F.

AU - Armanini, D.

PY - 2003/2

Y1 - 2003/2

N2 - In untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHDS) the presence of adrenal and testicular tumors had been described; however little is known about the effect of the enzymatic defect on fertility in males. We studied a male adult patient affected by 21OHDS for infertility, after a long period of discontinuation of glucocorticoid therapy and then during resumption of treatment and 8 months after monoadrenalectomy. The initial spermatic count revealed azoospermia and testicular needle aspiration showed a cytological picture consistent with prepuberty. The morphofunctional study revealed a right adrenal mass with reduced uptake at radioscan. Treatment was resumed with onset of impotency, which improved after reduction of the dose of glucocorticoids. The patient was monoadrenalectomised and his spermatic count increased. The patient shows that corticosteroid therapy in 21OHDS should be continued lifelong to avoid adrenal hyperplasia with possible areas of autonomy and to allow regular fertility. Impotence during treatment is probably due to a decrease of excessive adrenal androgens while testicular androgen production is still suppressed.

AB - In untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHDS) the presence of adrenal and testicular tumors had been described; however little is known about the effect of the enzymatic defect on fertility in males. We studied a male adult patient affected by 21OHDS for infertility, after a long period of discontinuation of glucocorticoid therapy and then during resumption of treatment and 8 months after monoadrenalectomy. The initial spermatic count revealed azoospermia and testicular needle aspiration showed a cytological picture consistent with prepuberty. The morphofunctional study revealed a right adrenal mass with reduced uptake at radioscan. Treatment was resumed with onset of impotency, which improved after reduction of the dose of glucocorticoids. The patient was monoadrenalectomised and his spermatic count increased. The patient shows that corticosteroid therapy in 21OHDS should be continued lifelong to avoid adrenal hyperplasia with possible areas of autonomy and to allow regular fertility. Impotence during treatment is probably due to a decrease of excessive adrenal androgens while testicular androgen production is still suppressed.

KW - 21-Hydroxylase deficiency syndrome

KW - Adrenal mass

KW - Impotence

KW - Infertility

UR - http://www.scopus.com/inward/record.url?scp=0037296204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037296204&partnerID=8YFLogxK

U2 - 10.1055/s-2003-37499

DO - 10.1055/s-2003-37499

M3 - Article

VL - 111

SP - 41

EP - 43

JO - Experimental and Clinical Endocrinology and Diabetes

JF - Experimental and Clinical Endocrinology and Diabetes

SN - 0947-7349

IS - 1

ER -